SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-002992
Filing Date
2024-02-08
Accepted
2024-02-08 16:11:10
Documents
1
Period of Report
2024-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6381
  Complete submission text file 0001209191-24-002992.txt   7835
Mailing Address 509 WATERVIEW PLACE NEW HOPE PA 18938
Business Address
Zakrzewski Joseph S (Reporting) CIK: 0001331852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40499 | Film No.: 24609195

Mailing Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)